Skip to content
FIND A BIOALPS ACTOR

News

If you would like your news to be listed here, please fill in the form to upload your information. Please note, we will only post news related to the life sciences.

Latest BioAlps news

Volumina Medical

Volumina Medical Gets a CHF 500 000 Loan from FIT

Volumina Medical is an EPFL spin-off based in Biopôle Lausanne. The company develops a biogel that supports the repair of…

Switzerland accepts medical devices with FDA approval

The Federal Council is to adapt national laws so that, in addition to medical devices with an EU certificate /…

ONWARD

EUR 3.7 million for ONWARD and its partners from the European Innovation Council (EIC)

The European Innovation Council Grant has been awarded to ONWARD and its research partners, including EPFL, IICT-BAS, CEA-Leti-Clinatec, and CEAList….

Limula

Limula wins the start-up Swiss Technology Award

During the Swiss Innovation Forum on 23 November 2022 in Basel, Limula won the Inventor Award.   Two other companies…

Cern et CHUV

CERN, CHUV and THERYQ develop a revolutionary FLASH radiotherapy device to fight cancer

This FLASH radiotherapy device will use very high-energy electrons (VHEE) to treat cancers that are resistant to conventional treatments, with…

BioAlps Awards

Prof. Jocelyne Bloch and Prof. Grégoire Courtine receive the BioAlps Academia Award, and Incyte the BioAlps Industry Award.

The ceremony closed the BioAlps Networking Day on 24 November 2022 in Neuchâtel, in front of 250 key players of…

Dentsply Sirona

Dentsply Sirona wins the Vaud International Business Award

The dental products world leader employs 700 people in the canton.       Each fall, the Vaud International Business…

Obseva

ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million

The Swiss company expects the sale proceeds to resolve its current over-indebtedness position ObsEva SA, a biopharmaceutical company based in…

Opna bio

Opna Bio Raises $38M in Series A Financing

Opna Bio, an Epalinges, Switzerland and San Francisco, CA-based clinical-stage biopharmaceutical company, raised $38M in Series A funding. The round…

nicollier

Claude Nicollier steps down from his position as CSEM

The former astronaut has spent 16 years as Chairperson of the Board of Directors   Effective June 2023, Claude Nicollier…

Novigenix

Novigenix announces first closing of its $20M Series B

The company validated its approach in Colorectal Cancer (CRC) screening, and provides new molecular insights and predictive algorithms for patient…

Neuria

Neuria receives the Start-Up Innovation Prize of the Canton of Fribourg

Neuria gets CHF 30 000 to develop its digital therapy hidden in video games to help fight nutrition disorders  …

Latest Republic of Innovation news

Loading RSS Feed